Acceleron Pharma
XLRN
#1908
Rank
A$15.87 B
Marketcap
A$259.51
Share price
0.00%
Change (1 day)
14,268.05%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: A$15.87 Billion

As of June 2026 Acceleron Pharma has a market cap of A$15.87 Billion. This makes Acceleron Pharma the world's 1908th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022A$16.06 B6.54%
2021A$15.07 B50.41%
2020A$10.02 B149.2%
2019A$4.02 B40.67%
2018A$2.85 B16.3%
2017A$2.45 B84.01%
2016A$1.33 B-40.07%
2015A$2.22 B44.42%
2014A$1.54 B22.68%
2013A$1.25 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$889.98 B 5,507.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$200.98 B 1,166.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$280.76 B 1,669.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$96.33 B 506.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$30.07 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
A$30.34 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
A$70.65 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA